Nora Doherty
Private Equity Investor bei BioCrossroads
Profil
Nora Doherty is currently working as the EVP, Finance & Managing Director of Seed Funds at BioCrossroads since 2003.
Prior to this, she worked as a Director at SonarMed, Inc. Ms. Doherty completed her undergraduate and MBA degrees from Indiana University.
Aktive Positionen von Nora Doherty
Unternehmen | Position | Beginn |
---|---|---|
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Private Equity Investor | 01.01.2003 |
Ehemalige bekannte Positionen von Nora Doherty
Unternehmen | Position | Ende |
---|---|---|
SonarMed, Inc.
SonarMed, Inc. Electronic Equipment/InstrumentsElectronic Technology SonarMed, Inc. develops medical devices. It offers AirWave, a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The firm’s product may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care. It operates through its offices located in Bryan and Carmel. The company was founded by Jeffrey P. Mansfield, Eduardo J. Juan and George R. Wodicka in 2005 and is headquartered in Carmel, IN. | Direktor/Vorstandsmitglied | - |
Ausbildung von Nora Doherty
Indiana University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
SonarMed, Inc.
SonarMed, Inc. Electronic Equipment/InstrumentsElectronic Technology SonarMed, Inc. develops medical devices. It offers AirWave, a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The firm’s product may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care. It operates through its offices located in Bryan and Carmel. The company was founded by Jeffrey P. Mansfield, Eduardo J. Juan and George R. Wodicka in 2005 and is headquartered in Carmel, IN. | Electronic Technology |
BioCrossroads
BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Finance |